Dear Ladies and Gentlemen,
dear business friends
we are pleased to inform you that we exclusively advised the shareholders of Laboratorium Dr. Deppe GmbH, Synersis GmbH as well as Cosmed GmbH (Dr. Deppe Group), located in Kempen, on the sale to Invision Capital Partners Ltd., Düsseldorf.
The Dr. Deppe Group is one of the leading suppliers of clinical disinfection products and wet wipes in Germany. The company, headquartered in Kempen, Germany, employs over 90 people and was founded in 1980 by Dr. Hans Dieter Deppe. Since then, under the management of the Deppe family, the group has grown successfully in Germany and abroad.
Laboratorium Dr. Deppe develops and produces disinfection, medical and biocidal products for various applications. The distribution of the products is concentrated on the B2B sector and supplies clinics, laboratories and medical practices as main customers. In addition, an extensive range of services for contract manufacturing and development for well-known customers has been developed over the years.
The disinfection and cleaning products can be used for skin and hands, surfaces, as well as medical instruments and accessories.
The own R&D department with laboratory allows a fast development and market introduction of new, innovative products. As a result, the group has now been able to achieve a leading position in the production of disinfectant wipes.
"In Invision, we have found an investor who will continue to successfully develop the company together with the existing management and actively support the growth geared towards expansion with entrepreneurial know-how, far-reaching expertise and an excellent network," emphasizes Carsten Häming, Managing Partner of CF-MB.
Invision has invested in the Dr. Deppe Group as part of a shareholding in order to support further growth. Further expansion of production in Kempen and internationalization of business activities are planned. In addition, Invision will support targeted acquisitions with further capital.
Peter Kroha, Invision partner and managing director in Germany: "Our investment in the Dr. Deppe Group is Invision's second growth investment within the last ten months in NRW. We are very pleased to be able to further develop the company together with the Deppe family and the entire team in the coming years. The Dr. Deppe Group is again a prime example of medium-sized family businesses in which Invision prefers to invest."
Titus Deppe will continue to manage the company operationally as Managing Director. He will be supported by his colleagues Oktay Cakmakci and Dr. Mark Derks.
Titus Deppe, Managing Partner: "As a long-standing family business, it was important for us to find an investment company that shares our vision for our company, understands our culture and has a good understanding of German SMEs. In Invision, we have found a partner who will continue to actively accompany the growth story of the Dr. Deppe Group with the same enthusiasm as our family."
"Within a few months, we were able to find an investor for the Dr. Deppe Group that perfectly met the criteria, values and demands of the shareholders. The successful handover of the company documents CF-MB's great efficiency and extensive expertise in corporate succession in the German SME sector," says Joachim von Brockhausen, Managing Partner of CF-MB.
Further details of the transaction were not disclosed.
